Evaluates a new autoantibody panel enhancing hepatocellular carcinoma diagnosis, suggesting improved screening effectiveness.
This novel serum autoantibody panel serves as a valuable diagnostic biomarker. Its combination with AFP significantly reduces missed diagnoses, offering a promising strategy to optimize HCC screening.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: